Get started
222

ANGIOLAB

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

251280 chart


Full chart

Key stats


Market capitalization
‪22.51 B‬KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−2.32 B‬KRW
Revenue (FY)
‪496.65 M‬KRW
Shares float
—
Beta (1Y)
−0.32

Employees


Employees (FY)
16
Change (1Y)
0
Revenue / Employee (1Y)
‪23.84 K‬KRW
Net income / Employee (1Y)
‪−111.39 K‬KRW

About ANGIOLAB


Sector
Health Technology
Industry
Biotechnology
CEO
Min-Yeong Kim
Website
angiolab.co.kr
Headquarters
Daejeon
Founded
1999
ISIN
KR7251280004
FIGI
BBG00F0XD231
AngioLab, Inc. engages in the development, manufacture, and distribution of pharmaceutical products. Its products include medicines for ophthalmic disorders, periodontal diseases, anti-obesity drugs, anti-inflammation treatments, and psoriasis cares, health functional foods for internal organ fat controls, and cosmetics for anti-wrinkle. The company was founded by Kim Min-Yeong on June 3, 1999 and is headquartered in Daejeon, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 251280 is 6,800 KRW — it has decreased by −10.30% in the past 24 hours. Watch ANGIOLAB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ANGIOLAB stocks are traded under the ticker 251280.
251280 stock has fallen by −3.00% compared to the previous week, the month change is a −5.69% fall, over the last year ANGIOLAB has showed a −5.56% decrease.
251280 reached its all-time high on Oct 29, 2018 with the price of 25,800 KRW, and its all-time low was 3,000 KRW and was reached on Mar 18, 2024. View more price dynamics on 251280 chart.
See other stocks reaching their highest and lowest prices.
251280 stock is 12.08% volatile and has beta coefficient of −0.32. Track ANGIOLAB stock price on the chart and check out the list of the most volatile stocks — is ANGIOLAB there?
Today ANGIOLAB has the market capitalization of ‪22.51 B‬, it has increased by 7.31% over the last week.
Yes, you can track ANGIOLAB financials in yearly and quarterly reports right on TradingView.
No, 251280 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 16.00 employees. See our rating of the largest employees — is ANGIOLAB on this list?
Like other stocks, 251280 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANGIOLAB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ANGIOLAB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ANGIOLAB stock shows the sell signal. See more of ANGIOLAB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.